What problem does this paper attempt to address?

The paper aims to explore the effects of growth hormone (GH) therapy on the onset and progression of puberty in girls with idiopathic short stature (ISS). Specifically, the study's objective is to assess whether GH therapy affects the timing of puberty onset, the duration of puberty, and the final height growth in ISS girls. The background of the study includes: - Idiopathic short stature (ISS) is a condition of unknown cause where the patient's height is significantly below the average for children of the same race, age, and gender by 2 standard deviations or below the 3rd percentile, excluding organic diseases and without a clear family history of short stature. - Growth hormone (GH) is a polypeptide hormone secreted by the pituitary gland, playing a crucial role in bone growth, muscle development, fat metabolism, and overall growth and development. GH therapy was initially used only for children with growth hormone deficiency (GHD), but with the advent of recombinant human growth hormone (rhGH) in the mid-1980s, GH began to be used for ISS children with significant effects. The study methods include: - The subjects were 541 ISS girls aged 4.5 to 10.6 years, of whom 126 were followed up to menarche. - Participants were divided into two groups: the ISS control group (n=66) and the treatment group (n=60) receiving daily GH therapy at a dose of 0.15 IU/kg. - Puberty development and GH usage were assessed every three months. The study results indicate: - There was no significant difference in the timing of puberty onset between the GH treatment group and the control group, but the duration of puberty was longer in the GH treatment group. - During puberty, there was no significant difference in height growth between the two groups. - The duration of GH therapy was significantly negatively correlated with female gonadal development and the age of menarche. The conclusion is: - GH therapy does not accelerate the onset of puberty but may prolong its duration, with no significant impact on height growth during puberty. - Longer GH therapy is associated with earlier female gonadal development and menarche. These findings provide important references for the clinical treatment of puberty development in ISS girls, helping doctors to formulate more reasonable treatment plans to maximize the growth and development of patients.

Effects of growth hormone therapy on the onset and progression of pubertal development in girls with idiopathic short stature